PT - JOURNAL ARTICLE AU - Alexis H Bennett AU - Marie-Francoise O’Donohue AU - Stacey R. Gundry AU - Aye T. Chan AU - Jeffery Widrick AU - Isabelle Draper AU - Anirban Chakraborty AU - Yi Zhou AU - Leonard I. Zon AU - Pierre-Emmanuel Gleizes AU - Alan H. Beggs AU - Vandana A Gupta TI - RNA helicase, DDX27 regulates proliferation and myogenic commitment of muscle stem cells AID - 10.1101/125484 DP - 2017 Jan 01 TA - bioRxiv PG - 125484 4099 - http://biorxiv.org/content/early/2017/04/07/125484.short 4100 - http://biorxiv.org/content/early/2017/04/07/125484.full AB - Developmental processes depend on the combined efforts of epigenetic, transcriptional and post-transcriptional processes that lead to the production of specific proteins that are important determinants of cellular identity and developmental processes. Ribosomes are a central component of the protein biosynthesis machinery in cells; however, their regulatory roles in the translational control of gene expression in an organ specific context during development remain to be defined. In a genetic screen to identify critical regulators of myogenesis, we identified a DEAD-Box RNA helicase, DDX27, that is required for the proliferation and myogenic commitment of skeletal muscle stem cells. DDX27 deficient skeletal muscle exhibits hypotrophy and impaired regeneration potential. We demonstrate that DDX27 regulates ribosomal RNA (rRNA) maturation, and thereby the ribosome biogenesis and the translation of specific transcripts that are required to maintain pluripotency and myogenic differentiation of satellite cells. These findings provide insight into the translational regulation of gene expression in myogenesis and suggest novel functions for ribosomes in regulating gene expression during skeletal muscle development.AUTHOR SUMMARY Inherited skeletal muscle diseases are the most common form of genetic disorders with primary abnormalities in the structure and function of skeletal muscle resulting in the impaired locomotion in affected patients. A major hindrance to the development of effective therapies is a lack of understanding of biological processes that promote skeletal muscle growth. By performing a forward genetic screen in zebrafish we have identified mutation in a RNA helicase that leads to perturbations of ribosomal biogenesis pathway and impairs skeletal muscle growth and regeneration. Therefore, our studies have identified novel ribosome-based disease processes that may be therapeutic modulated to restore muscle function in skeletal muscle diseases.